vs
NORTHPOINTE BANCSHARES INC（NPB）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是NORTHPOINTE BANCSHARES INC的1.2倍（$75.5M vs $63.4M）
Northpointe Bancshares Inc是一家美国银行控股公司，通过旗下全资银行子公司开展业务，提供各类零售及商业银行服务，涵盖存款账户、住房抵押贷款、小微企业信贷、财富管理等，主要服务美国本土区域社区客户。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
NPB vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.2倍
$63.4M
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $63.4M | $75.5M |
| 净利润 | $22.2M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | — | 22.7% |
| 净利率 | 34.9% | — |
| 营收同比 | — | 27.7% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.62 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NPBPBYI
| Q1 26 | $63.4M | — | ||
| Q4 25 | $43.5M | $75.5M | ||
| Q3 25 | $40.3M | $54.5M | ||
| Q2 25 | $36.5M | $52.4M | ||
| Q1 25 | $30.4M | $46.0M | ||
| Q4 24 | — | $59.1M | ||
| Q3 24 | — | $80.5M | ||
| Q2 24 | — | $47.1M |
净利润NPBPBYI
| Q1 26 | $22.2M | — | ||
| Q4 25 | $23.6M | — | ||
| Q3 25 | $22.2M | $8.8M | ||
| Q2 25 | $20.3M | $5.9M | ||
| Q1 25 | $17.2M | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $20.3M | ||
| Q2 24 | — | $-4.5M |
毛利率NPBPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% |
营业利润率NPBPBYI
| Q1 26 | — | — | ||
| Q4 25 | 73.5% | 22.7% | ||
| Q3 25 | 72.3% | 17.6% | ||
| Q2 25 | 73.0% | 12.7% | ||
| Q1 25 | 74.4% | 8.7% | ||
| Q4 24 | — | 22.6% | ||
| Q3 24 | — | 27.4% | ||
| Q2 24 | — | -4.6% |
净利率NPBPBYI
| Q1 26 | 34.9% | — | ||
| Q4 25 | 54.4% | — | ||
| Q3 25 | 55.0% | 16.2% | ||
| Q2 25 | 55.7% | 11.2% | ||
| Q1 25 | 56.8% | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 25.2% | ||
| Q2 24 | — | -9.6% |
每股收益（稀释后）NPBPBYI
| Q1 26 | $0.62 | — | ||
| Q4 25 | $0.54 | $0.26 | ||
| Q3 25 | $0.57 | $0.17 | ||
| Q2 25 | $0.51 | $0.12 | ||
| Q1 25 | $0.49 | $0.06 | ||
| Q4 24 | — | $0.40 | ||
| Q3 24 | — | $0.41 | ||
| Q2 24 | — | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $487.6M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $590.0M | $130.3M |
| 总资产 | $7.4B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资NPBPBYI
| Q1 26 | $487.6M | — | ||
| Q4 25 | $496.5M | $97.5M | ||
| Q3 25 | $419.2M | $94.4M | ||
| Q2 25 | $415.7M | $96.0M | ||
| Q1 25 | $321.5M | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M |
总债务NPBPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M |
股东权益NPBPBYI
| Q1 26 | $590.0M | — | ||
| Q4 25 | $569.0M | $130.3M | ||
| Q3 25 | $623.5M | $115.3M | ||
| Q2 25 | $604.3M | $104.7M | ||
| Q1 25 | $586.5M | $97.1M | ||
| Q4 24 | — | $92.1M | ||
| Q3 24 | — | $71.1M | ||
| Q2 24 | — | $48.5M |
总资产NPBPBYI
| Q1 26 | $7.4B | — | ||
| Q4 25 | $7.0B | $216.3M | ||
| Q3 25 | $6.8B | $202.9M | ||
| Q2 25 | $6.4B | $194.9M | ||
| Q1 25 | $5.9B | $196.2M | ||
| Q4 24 | — | $213.3M | ||
| Q3 24 | — | $220.7M | ||
| Q2 24 | — | $205.0M |
负债/权益比NPBPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流NPBPBYI
| Q1 26 | — | — | ||
| Q4 25 | $-28.3M | $14.4M | ||
| Q3 25 | $90.4M | $9.7M | ||
| Q2 25 | $-72.3M | $14.1M | ||
| Q1 25 | $54.4M | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M |
自由现金流NPBPBYI
| Q1 26 | — | — | ||
| Q4 25 | $-28.8M | $14.4M | ||
| Q3 25 | $89.6M | $9.7M | ||
| Q2 25 | $-73.4M | $14.1M | ||
| Q1 25 | $54.1M | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M |
自由现金流率NPBPBYI
| Q1 26 | — | — | ||
| Q4 25 | -66.1% | 19.1% | ||
| Q3 25 | 222.3% | 17.7% | ||
| Q2 25 | -201.1% | 26.8% | ||
| Q1 25 | 178.0% | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% |
资本支出强度NPBPBYI
| Q1 26 | — | — | ||
| Q4 25 | 1.2% | 0.0% | ||
| Q3 25 | 2.0% | 0.0% | ||
| Q2 25 | 3.1% | 0.0% | ||
| Q1 25 | 1.1% | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% |
现金转化率NPBPBYI
| Q1 26 | — | — | ||
| Q4 25 | -1.20× | — | ||
| Q3 25 | 4.08× | 1.10× | ||
| Q2 25 | -3.55× | 2.41× | ||
| Q1 25 | 3.16× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NPB
| Net Interest Income | $41.3M | 65% |
| Noninterest Income | $22.1M | 35% |
PBYI
暂无分部数据
